Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:administeredBy |
gptkb:U.S._Department_of_Health_and_Human_Services
|
| gptkbp:appliesTo |
gptkb:United_States
|
| gptkbp:approvedBy |
emergency use of unapproved medical products
|
| gptkbp:codifiedIn |
Public Law 108-276
|
| gptkbp:dateEnacted |
July 21, 2004
|
| gptkbp:enables |
expedited research and development of countermeasures
government contracts with pharmaceutical companies stockpiling of vaccines and treatments |
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| gptkbp:fundedBy |
$5.6 billion over 10 years
|
| https://www.w3.org/2000/01/rdf-schema#label |
Project BioShield Act
|
| gptkbp:provides |
funding for the development and procurement of medical countermeasures
|
| gptkbp:purpose |
to provide protections and countermeasures against chemical, biological, radiological, and nuclear (CBRN) threats
|
| gptkbp:relatedLegislation |
gptkb:21st_Century_Cures_Act
gptkb:Pandemic_and_All-Hazards_Preparedness_Act |
| gptkbp:relatedTo |
public health emergency preparedness
bioterrorism |
| gptkbp:section |
Homeland Security Act amendments
|
| gptkbp:signedBy |
gptkb:George_W._Bush
|
| gptkbp:bfsParent |
gptkb:乔治·W·布什
|
| gptkbp:bfsLayer |
5
|